Medtronic's diabetes care unit has grown faster than the rest of its business in recent years. Over the past few years, ...

Medtronic’s move to turn its diabetes division into a separate company allows it to step away from a lower-profit, ...

Medtronic’s decision to spin out its diabetes division into a separate entity marks a major shift — one that allows the medical device giant to shed a lower-margin, consumer-facing business ...

Valued at $106.4 billion by market cap, Medtronic plc (MDT) is one of the world’s largest medical device companies, ...

The global AI in Remote Patient Monitoring Market valued at US$1551.8 million in 2023, stood at US$1,967.7 million in 2024 ...

We came across a bullish thesis on Medtronic plc (MDT) on Investing Intel’s Substack. In this article, we will summarize the ...

Revascularisation of multivessel coronary artery disease (MVD) can be accomplished by either percutaneous coronary ...

Verizon and Medtronic offer high yields, growth potential, and undervalued prices. Perfect picks for conservative, long-term ...

CEO Sean Saint and CFO Stephen Feider spoke about what’s different now that the company is public and the long journey of ...

As part of Big League's 'Catching Up With' series in 2025, we sat down with Steve Renouf to reflect on a dazzling career.

IPO drought, the industry is questioning whether the window for medtech public offerings is open following a small burst of ...

The global drug device combination products market, valued at US$224.70 billion in 2024, stood at US$243.02 billion in 2025 ...